Your browser doesn't support javascript.
loading
Treatment of chancroid with spectinomycin or co-trimoxazole.
Traisupa, A; Ariyarit, C; Metheeprapha, C; Buatiang, A; Sungthong, P.
Afiliación
  • Traisupa A; Department of Communicable Disease Control, Ministry of Public Health, Bangkok, Thailand.
Clin Ther ; 12(3): 200-5, 1990.
Article en En | MEDLINE | ID: mdl-2165860
ABSTRACT
Chancroid, the third most prevalent venereal disease in Thailand, was treated with a single 2-gm dose of spectinomycin, or two tablets of co-trimoxazole (trimethoprim-sulfamethoxazole) twice daily for seven days. The differences in cure rates between the two groups were statistically significant. The chancroidal ulcers were cured in 93.7% of 175 patients treated with spectinomycin, and in 48.2% of 168 co-trimoxazole-treated patients (P less than 0.01). The in vitro susceptibility of Haemophilus ducreyi to spectinomycin was 4 to 16 micrograms/ml and to co-trimoxazole 32 micrograms/ml or higher. Thus we found that a single-dose regimen of spectinomycin was significantly more effective than the standard seven-day regimen of co-trimoxazole for the treatment of chancroid.
Asunto(s)
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Chancroide / Combinación Trimetoprim y Sulfametoxazol / Espectinomicina Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Humans / Male / Middle aged Idioma: En Año: 1990 Tipo del documento: Article
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Chancroide / Combinación Trimetoprim y Sulfametoxazol / Espectinomicina Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Humans / Male / Middle aged Idioma: En Año: 1990 Tipo del documento: Article